Barriers to accessing opioid agonist therapy in pregnancy.  Bedrick BS, O'Donnell C, Marx CM, Friedman H, Carter EB, Stout MJ, Kelly JC.  Am J Obstet Gynecol MFM. 2020 Nov;2(4):100225. doi: 10.1016/j.ajogmf.2020.100225. Epub 2020 Sep 1...

Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis.  Link HM, Jones H, Miller L, Kaltenbach K, Seligman N.  Am J Obstet Gynecol MFM. 2020 Aug;2(3):100179. doi: 10.1016/j.ajogmf.2020.100179. Epub 2020 Jul...

Medication-assisted treatment vs. detoxification for women who misuse opioids in pregnancy: Associations with dropout, relapse, neonatal opioid withdrawal syndrome (NOWS), and childhood sexual abuse.  Macfie J, Towers CV, Fortner KB, Stuart ...

Use of Injectable Opioid Agonist Therapy in a In-Patient Setting for a Pregnant Patient With Opioid Use Disorder: A Case Report.  Griffiths S, Campbell DM, Caudarella A, Guimond T, Lamba W, Lurie E, Nader M, Sgro M, Turner S.  J Addict...

Maintenance agonist treatments for opiate-dependent pregnant women.  Minozzi S, Amato L, Jahanfar S, Bellisario C, Ferri M, Davoli M.  Cochrane Database Syst Rev. 2020 Nov 9;11:CD006318. doi: 10.1002/14651858.CD006318.pub4. PMID: 33165...

Pregnancy and Substance Use – A Harm Reduction Toolkit NATIONAL HARM REDUCTION COALITION in Collaboration with Academy of Perinatal Harm Reduction  http://fileserver.idpc.net/library/Preg_Subst_Use_Harm_Reduction_Toolkit.pdf